Modern therapeutic potential of super-selective β<sup>1</sup>-adrenoblocker nebivolol
Beta-adrenoblockers, included in any cardiovascular disease treatment standard, became a key part of clinical practice only in late XX century. Nebivolol is a highly selective beta-1 -adrenoiblocker, modulating endothelial NO release and subsequent physiological vasodilatation. Nebivolol has multipl...
Saved in:
Main Authors: | V. I. Makolkin, D. A. Napalkov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
1970-01-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1799 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
RATIONAL CHOICE OF Β-ADRENOBLOCKERS IN CHRONIC HEART FAILURE THERAPY
by: M. L. Maximov
Published: (2015-12-01) -
Modern views on β-adrenoblocker therapy in elderly patients with chronic heart failure
by: E. V. Privalova
Published: (2007-06-01) -
Pharmacokinetics and pharmacodynamics of a β-adrenoblocker bisoprolol: from mechanisms of action to clinical features
by: O. D. Ostroumova, et al.
Published: (2011-06-01) -
Differential beta-adrenoblocker therapy in chronic heart failure
by: S. N. Tereshchenko, et al.
Published: (1970-01-01) -
THE PLACE OF NEBIVOLOL IN RATIONAL THERAPY OF CONGESTIVE HEART FAILURE
by: A. B. Khadzegova
Published: (2014-09-01)